← Leaderboards
Wei Ding
Mayo Clinic Rochester
$837,000
Attributed
$837,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $167.4K · FY2011–15$200K$150K$100K$50K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$837,000 · 1
By mechanism
K23$837,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Tait D Shanafelt$9,008,119
- Evanthia Galanis$13,573,895
- Veena Taneja$2,103,609
- Kah-Whye Peng$11,311,466
- Yi Lin$6,996,175
Others in their field
Top investigators on “Alemtuzumab”
- Allan D. Kirk · Emory University$7,879,211
- Stuart Johnston Knechtle · University Of Wisconsin Madison$6,594,620
- John C Byrd · University Of Cincinnati$5,627,856
- Nelson J. Chao · Duke University$4,739,512
- Thomas S. Kupper · Dana-Farber Cancer Institute$3,708,368
- Laura Z Rassenti · University Of California, San Diego$2,925,882
Research focus
AlemtuzumabAlkylating AgentsAntibodiesApoptosisBiological ModelsBiologyBiomedical ResearchB-LymphocytesCareerCareer DevelopmentCell PhysiologyCell ProliferationCellsCell StromaCell SurvivalCell TypeChemotherapyChlorambucilChronic Lymphocytic LeukemiaClinicClinical EfficacyClinical InvestigatorClinical ResearchAdhesions
Grant awards (5)
Targeting Akt Activation in CLL$167,400
K23 · FY2015 · CA · contact PI
Targeting Akt Activation in CLL$167,400
K23 · FY2014 · CA · contact PI
Targeting Akt Activation in CLL$167,400
K23 · FY2013 · CA · contact PI
Targeting Akt Activation in CLL$167,400
K23 · FY2012 · CA · contact PI
Targeting Akt Activation in CLL$167,400
K23 · FY2011 · CA · contact PI